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23 ABSTRACT
24 Purpose: Blackcurrant extract mainly contains anthocyanins. Several reports suggest that 
25 anthocyanins have beneficial effect for cardiovascular functions. The aim of this study was to 
26 examine the effect of 7-day intake of New Zealand blackcurrant (NZBC) extract on arterial 
27 functions, e.g. arterial stiffness, and serum lipids.
28 Methods: A randomized, double-blind, placebo-controlled, crossover design study with a 
29 washout period of 28 days was conducted. Fourteen older adults participated in this study (age 
30 73.3 ± 1.7 years). Participants took either a 7-day course of placebo or two capsules of NZBC 
31 extract (each 300 mg capsule contains 35% blackcurrant extract). Participants took one of the 
32 two trials first and then took the other after a washout period. Carotid-femoral pulse-wave 
33 velocity, an index of central arterial stiffness, and central blood pressure were measured at 
34 baseline and again at the end of the 7-day study period.
35 Results: Compared to baseline, carotid-femoral pulse-wave velocity (P = 0.03) and central 
36 blood pressure (P = 0.02) decreased significantly after the 7-day study period with NZBC 
37 intake. In addition, carotid-femoral pulse-wave velocity (P = 0.04) and central blood pressure 
38 (P = 0.001) in the NZBC intake trial decreased significantly more than in the placebo intake 
39 trial. No effects were observed on serum lipids.
40 Conclusion: These results suggest that short-term NZBC intake reduces central arterial 
41 stiffness and central blood pressure in older adults. Therefore, anthocyanin-rich blackcurrants 
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42 might be beneficial for maintaining or improving cardiovascular health as an alternative to 
43 pharmaceutical medications.
44
45 Key words: Anthocyanins, Pulse wave velocity, Augmentation index, Vascular function, 
46 Cardiovascular risk factors
47
48 Abbreviations
49 AIx, augmentation index; BP, blood pressure; cfPWV, carotid–femoral pulse-wave velocity; 
50 CVD, cardiovascular diseases; DBP, diastolic blood pressure; faPWV, femoral-ankle pulse-
51 wave velocity; FG, fasting glucose; HDL, high-density lipoprotein cholesterol; LDL, low-
52 density lipoprotein cholesterol; MBP, mean blood pressure; NZBC, New Zealand blackcurrant; 
53 PP, pulse pressure, SBP, systolic blood pressure; TG, triglycerides
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54 INTRODUCTION
55 Mortality due to cardiovascular disease is a serious global problem (1), and many 
56 strategies are needed to prevent cardiovascular disease. An increase in central arterial stiffness 
57 as assessed by carotid-femoral pulse wave velocity (cfPWV) is a powerful predictor of future 
58 cardiovascular events, such as myocardial infarction or stroke, and all-cause mortality (2-4). In 
59 addition, central aortic blood pressure (BP) has greater prognostic capability than brachial BP, 
60 and is more strongly related to vascular hypertrophy, the extent of atherosclerosis, and other 
61 cardiovascular events (3-6). Therefore, minimizing increases in central arterial stiffness and 
62 central BP are important for the prevention of cardiovascular disease (CVD).
63 In previous randomized trials, it has been reported that consumption of polyphenols 
64 from foods or extracts significantly improved vascular health. In fact, polyphenol-rich foods 
65 such as berries, chocolate, or cocoa reduced brachial BP or central arterial stiffness and 
66 improved vascular endothelial function (7,8). Prospective studies investigating the association 
67 between flavonoid consumption and myocardial infarction risk in young and middle-aged 
68 adults showed that high intake of anthocyanins present in blueberries and strawberries is 
69 associated with a decreased risk of myocardial infarction (9). Anthocyanins are among the 
70 polyphenols that are part of the flavonoid family. Anthocyanins have potent antioxidant 
71 capacity and/or a powerful vasodilator effect by producing nitric oxide (10-13). It is known 
72 that short-term anthocyanin consumption significantly reduces arterial stiffness and improves 
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73 vascular endothelial function compared to placebo in young and middle-aged adults (14-17). 
74 In addition, according to a meta-analysis by Fairlie-Jones et al.(18) acute intake of anthocyanin 
75 significantly improved arterial stiffness in healthy young adults. On the other hand, 
76 blackcurrants include specific anthocyanins, consisting primarily of delphinidin-3-rutinoside, 
77 delphinidin-3-glucoside, cyanidin-3-rutinoside, and cyanidin-3-glucoside, which have 
78 numerous health benefits (19,20). Thus, intake of anthocyanin-rich blackcurrants may have a 
79 number of beneficial effects on cardiovascular health. However, to the best of our knowledge, 
80 the effects of short-term blackcurrant consumption on central arterial stiffness and central BP 
81 in older adults are unknown. More research is needed to determine various strategies to achieve 
82 cardioprotective effects in older adults.
83 The aim of this study was to examine the effect of 7-day intake of New Zealand 
84 blackcurrant (NZBC) extract on arterial functions, such as arterial stiffness and serum lipids. 
85 We hypothesized that short-term NZBC intake reduces central arterial stiffness and blood 
86 pressure in older adults. 
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89 This was a double-blind, randomized, placebo-controlled, crossover study. 
90
91 Participants
92 Fourteen volunteers (female: 8, male: 6) more than 65 years old were recruited from 
93 the area near Nippon Sport Science University in Japan. Figure 1 shows the flow diagram of 
94 enrollment and trial assignment of the participants. Inclusion criteria were: 1. non-smoking; 2. 
95 not obese (body mass index ≤30 kg/m2); 3. ≥65 years of age; 4. no history of cardiovascular 
96 disease or diabetes; 5. no diseases or disorders affecting their daily life; 6. not taking medication 
97 that compromises the cardiovascular system, including antihyperlipidemic, antihypertensive, 
98 or antihyperglycemic medications; 7. not taking supplementation; 8. not taking habitual 
99 exercise; 9. postmenopausal women; and 10. not taking hormone replacement therapy. The 
100 inclusion criteria of each participant were confirmed by the authors during screening before the 
101 experiment. The number of participants who met the inclusion criteria and who were willing 
102 to participate in this study totaled 14 (female: 8, male: 6). Written, informed consent was 
103 obtained from all participants after providing detailed explanations of the potential risks of the 
104 study. A health history questionnaire was completed to confirm health states. Table 1 shows 
105 the physical characteristics of the participants. The study protocol was approved by the ethics 
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106 committee of Nippon Sport Science University (Japan) (018-H087). 
107
108 Schedule
109 Participants visited the laboratory four times at the same time in the morning (8:00 
110 am). Figure 2 shows the experimental schedule. Before arrival, participants were instructed to 
111 avoid vigorous exercise for 48 hours, alcohol for 24 hours and caffeine-containing products on 
112 the day of testing and be fasted for at least 10–14 hours overnight.
113 At every visit, arterial stiffness and BP were measured and blood samples collected 
114 from the ulnar vein of the nondominant arm of each participant.
115
116 NZBC and placebo intake
117 Participants ingested 2 × 300 mg capsules (total 210 mg of anthocyanins) of 
118 concentrated NZBC extract or a visually identical placebo for 7 days. Each 300 mg NZBC 
119 capsule contained 105 mg of anthocyanins, consisting of 35–50% delphinidin-3-rutinoside, 5–
120 20% delphinidin-3-glucoside, 30–45% cyanidin-3-rutinoside, and 3–10% cyanidin-3-
121 glucoside (CurraNZ®, Health Currancy Ltd., Surrey, UK). Each placebo capsule contained 
122 300 mg microcrystalline cellulose. Two capsules were consumed with breakfast for the first 6 
123 days. On the final morning of the supplementation period, participants were instructed to take 
124 the supplement or placebo without breakfast, with the last intake about 2 h before an 
Page 7 of 38
URL: http:/mc.manuscriptcentral.com/lceh  Email: mlokhandwala@uh.edu





























































For Peer Review Only
8
125 experimental visit. The two experimental conditions (NZBC extract and placebo) were 
126 separated by a 4-week washout period (21). Intake of beverages such as green tea and/or dietary 
127 supplements that included polyphenols were prohibited during the study. No restrictions were 
128 placed on food intake, but all participants were instructed to maintain their normal diet and 
129 lifestyle throughout the study period.
130
131 Body composition
132 The body composition of the participants was determined by bioelectric impedance 
133 using a body-composition analyzer (InBody770, Biospace Co Ltd, Seoul, South Korea).
134
135 Arterial stiffness
136 cfPWV and femoral–ankle PWV (faPWV), which reflect aortic and leg arterial 
137 stiffness, respectively, were measured. Carotid and femoral artery-pressure waveforms were 
138 obtained for 30 seconds using arterial applanation tonometry incorporating form PWV/ABI 
139 micropiezoresistive transducers (Omron-Colin Co Ltd, Tokyo, Japan), which comprise 15 
140 aligned pressure-sensitive elements that can identify carotid and femoral pulse traces, arranged 
141 side by side and attached to the left common carotid and femoral arteries, respectively. A 
142 vascular testing device (form PWV/ABI; Omron-Colin) was used to measure simultaneously 
143 electrocardiograms, bilateral brachial and ankle BP, and carotid-arterial and femoral-arterial 
Page 8 of 38
URL: http:/mc.manuscriptcentral.com/lceh  Email: mlokhandwala@uh.edu





























































For Peer Review Only
9
144 pulse waves (PWs). cfPWV and faPWV were calculated by dividing the distance between the 
145 two arterial recording sites by the transit time, which is determined based on the time delay 
146 between the proximal and distal “foot” waveforms. faPWV is calculated based on the transit 
147 time between the femoral artery site and the ankle site. Next, time delays were obtained from 
148 between the right brachial and posttibial arteries, the carotid and femoral arteries (Tcf), and the 
149 femoral and posttibial arteries. A nonelastic tape measure was then used to make duplicate 
150 random zero-length measurements over the body surface in order to determine the path length 
151 from the carotid to the femoral artery (Dcf). cfPWV was calculated using the following 
152 equation:
153
154 cfPWV = Dcf/Tcf 
155
156 The investigator who performed the PWV measurements was blinded to the condition 
157 assignment of the participants.
158
159 Central and brachial BPs and the augmentation index (AIx)
160 Arterial pulse waveforms of the left radial artery for estimating central BP were 
161 measured non-invasively by an automated tonometric system (HEM-9000AI, Omron 
162 Healthcare Co., Ltd.). Central BP and the AIx were measured as previously described (22,23). 
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163 Brachial BP was measured with an oscillometric manometer, and radial pulse waveforms were 
164 recorded non-invasively using an applanation tonometer. Signals of the radial arterial pressure 
165 wave were low-pass-filtered, first at a cut-off frequency of 105 Hz to remove high-frequency 
166 noise and then at 25 Hz to extract pressure waveforms. Inflection points or peaks that 
167 corresponded to first (early) and second (late) systolic BP were automatically identified using 
168 the fourth derivative wave as the second and third zero crossing points, respectively. Late SBP 
169 in the radial artery was used as an estimate of the central SBP and was calculated using the 
170 following equation:
171 Late SBP= (P2/PP) x (SBP-DBP) + DBP
172 In addition, the radial AIx was calculated using the following equation:
173 AIx(%)= (P2/PP) x 100
174 where P2 is the pressure difference between the peak systolic pressure and an early inflection 
175 point that indicates the beginning upstroke of the reflected pressure wave, and PP is the pulse 
176 pressure.
177 The AIx was adjusted for a heart rate of 75 bpm (AIx@75).
178 In addition, mean brachial BP (MBP) and brachial pulse pressure (PP) were calculated 
179 using the following equations:
180 MBP = [DBP + (SBP – DBP) / 3].
181 PP = SBP – DBP
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182
183 Serum lipids profile and glucose
184 Whole blood was drawn into serum separator tubes, allowed to clot and centrifuged at 
185 4,000 RCF for 15 minutes. Triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), 
186 low-density lipoprotein cholesterol (LDL-C) and fasting glucose (FG) in blood samples were 
187 measured using standard enzymatic techniques. The intra- and interassay coefficients of 
188 variance was less than 5%.
189
190 Statistics
191 All data are expressed as means ± standard error. Statistical analyses were performed 
192 using statistical software (SPSS ver. 24; SPSS, Inc., Chicago, IL, USA). The assumption of a 
193 normal distribution for all data was verified using the Kolmogorov–Smirnov test, and all data 
194 were normally distributed. Data were analyzed using two-way analysis of variance (trials × 
195 periods) with repeated measures. When the main effect or interaction was significant, the paired 
196 t-test was used to identify significant differences among the mean values. Statistical 
197 significance was set at P < 0.05. In addition, The interpretation of p as 0.05 > p ≤ 0.1 was 
198 according to guidelines by Curran-Everett and Benos (24).
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199 RESULTS
200 Figure 3 shows changes in cfPWV before and after both NZBC and placebo. The 
201 cfPWV at baseline did not differ significantly between NZBC and placebo. cfPWV decreased 
202 significantly after NZBC intake compared with baseline values (P = 0.03). In contrast, the 
203 cfPWV did not differ significantly between before and after placebo intake. Significant 
204 differences in cfPWV were observed between the NZBC and placebo after intervention (P = 
205 0.04).
206 Figure 4 shows changes in central BP before and after both NZBC and placebo. The 
207 central BP at baseline did not differ significantly between NZBC and placebo. Central BP 
208 decreased significantly after NZBC intake compared with baseline values (P = 0.02). In 
209 contrast, the central BP did not differ significantly before and after placebo intake. Significant 
210 differences in central BP were observed between the NZBC and placebo after intervention (P 
211 = 0.001).
212 Table 2 shows changes in brachial SBP, DBP, MBP, PP, AIx, and faPWV before and 
213 after NZBC and placebo. The brachial SBP, DBP, MBP, PP, AIx, and faPWV at baseline did 
214 not differ significantly between NZBC and placebo. Brachial SBP (P = 0.03), DBP (P = 0.02), 
215 MBP (P = 0.01), and AIx (P = 0.03) decreased significantly after NZBC intake compared with 
216 baseline values. PP had a tendency to decrease after NZBC intake compared with baseline 
217 values (P = 0.09). In contrast, brachial SBP, DBP, MBP, PP and AIx did not differ significantly 
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218 between before and after placebo intake. Significant differences in brachial SBP (P = 0.001), 
219 MBP (P = 0.01), PP (P =0.01), and AIx (P =0.01) were observed between the NZBC and 
220 placebo trials after intervention (P = 0.001). There was a trend for DBP to be lower with NZBC 
221 trial compared with placebo trial after intervention (p = 0.07). On the other hand, faPWV did 
222 not differ significantly between before and after both NZBC and placebo. In addition, no 
223 significant differences in faPWV were observed between the NZBC and placebo trials after 
224 intervention.
225 Table 3 shows changes in serum lipids profile before and after both NZBC and placebo. 
226 No significant differences were seen between NZBC and placebo in serum concentrations of 
227 TG, HDL-C, LDL-C, or FG at baseline. No significant changes were observed between the two 
228 trials in serum concentrations of TG, HDL-C, LDL-C, or FG after both NZBC and placebo.
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229 DISCUSSION
230 The key finding of this study was that 7 days intake of anthocyanin-rich NZBC in 
231 older adults decreased cfPWV and cSBP with no changes in the placebo condition. These 
232 results suggest that short-term intake of NZBC would decrease central arterial stiffness and BP 
233 in older adults.
234 An increase in central arterial stiffness and/or central BP has been shown to be 
235 independently associated with future cardiovascular events, such as myocardial infarction or 
236 stroke, and all-cause mortality (25,26). Therefore, intake of NZBC may be an important type 
237 of non-pharmacological therapy to enhance cardiovascular health in older adults.
238 The present findings show for the first time that anthocyanin-rich foods such as NZBC 
239 reduce arterial stiffness in older adults. Anthocyanins are flavonoids, all of which are phenolic 
240 compounds (i.e., polyphenols). Recent studies have shown that ingestion of anthocyanins-rich 
241 foods, including black currants, blueberries, grapes, and purple potatoes, have the beneficial 
242 effects of reducing arterial stiffness in both young and middle-aged adults, and growing 
243 evidence highlights that specific flavonoids from plant bioactive compounds present in fruits 
244 improve vascular function (27,28). Some previous studies that examined the associations 
245 between anthocyanin intake and arterial stiffness focused predominantly on young and middle-
246 aged participants. In our recent study, it was shown that intake of polyphenol-rich cocoa 
247 reduced cfPWV in postmenopausal women (8). In addition, previous studies showed an 
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248 association between polyphenol-rich food intake and decreased aortic stiffness in healthy adults, 
249 independent of age (3,4,29,30). Consistent with previous studies (8,31), the present results 
250 suggest that intake of polyphenol-rich foods, i.e. anthocyanin-rich blackcurrant, improves 
251 central arterial stiffness. Thus, the present findings expand on previous research on the effects 
252 of polyphenol-rich foods on arterial stiffness in older adults.
253 In addition to the improvements in central arterial stiffness, 7-day intake of NZBC 
254 extract was shown, for the first time, to reduce central BP by average of 10 mmHg, which 
255 appears to be a better predictor of cardiovascular events than brachial BP (3-6). Wang et al. 
256 (32) observed central BP reductions of 6 mmHg that reduced cardiovascular mortality by 
257 approximately 25%. Thus, the present findings showed that NZBC intake reduced central BP, 
258 suggesting the effectiveness of anthocyanin-rich foods for reducing central BP.
259 In the previous meta-analyses of randomized controlled trials, consumption of 
260 flavonoid-rich foods (e.g., green tea, soy protein isolates, and cocoa or chocolate) was shown 
261 to reduce peripheral (brachial) BP (33). Consistent with a previous study, the present findings 
262 showed that intake of NZBC reduced brachial BP. Moreover, NZBC intake reduced the AIx. 
263 The central aortic pressure wave consists of a forward traveling wave generated by left 
264 ventricular ejection, followed by a later-arriving reflected wave from the periphery (34). In 
265 addition, as arterial stiffness increases, central BP increases can occur due to increased forward 
266 and reflected wave amplitudes and earlier return of the reflected wave to the proximal aorta. 
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267 Reduction in the AIx is associated with increased peripheral vasodilation (35), caused by 
268 decreased wave reflection at medium-sized muscular arteries (36). Therefore, the decreased 
269 AIx in the present study may have been caused by peripheral vasodilation. Moreover, the 
270 measurements of arterial stiffness obtained from non-invasive pressure waveforms suggested 
271 that decreased aortic stiffness is associated with reduced AIx (37). Thus, the present findings 
272 suggest that the changes in central arterial stiffness and BP after NZBC intake were primarily 
273 the result of changes in arterial distension. Aortic stiffness affects both early systolic cardiac 
274 load, through elevation of the forward pressure wave, and late systolic cardiac load, due to 
275 earlier return of the reflected pressure wave (38-42). Thus, the present findings suggested that 
276 the effect of NZBC intake was mediated by reductions in both early systolic and late systolic 
277 pressures, suggesting decreased aortic stiffness and arteriolar tone, respectively. Therefore, 
278 since decreased wave reflection decreases LV afterload and myocardial oxygen demand (43), 
279 NZBC intake appears to be effective for reducing cardiovascular risk in older adults.
280 In the present study, there were no differences in serum lipids and glucose after intake 
281 of NZBC or placebo. Alvarez-Suarez et al. (44) reported that one-month intake of anthocyanin-
282 rich strawberry improved the lipid profile by significantly reducing TC, LDL-C, and TG levels 
283 compared to baseline levels, while no changes were seen in HDL cholesterol. In this respect, 
284 the present results differ from that of previous study. One possible reason for this difference 
285 may be differences in the subjects and intake duration among studies. Moreover, since TC, 
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286 LDL-C, and TG in most participants of the present study were within the standard ranges, their 
287 values might not have differed from baseline values. In addition, Tsang et al. (28) reported that 
288 intake of an anthocyanin-rich potato did not change glucose. This result is consistent with our 
289 findings. Thus, the present findings showed that NZBC intake did not change serum lipid 
290 profile and glucose in older adults.
291 In individuals at risk, medical and pharmacologic interventions can decrease 
292 cardiovascular mortality, but such interventions are costly and may have adverse effects 
293 (45,46). In contrast, in epidemiological studies, higher anthocyanin intake was associated with 
294 decreased arterial stiffness and BP (47,48). Increased arterial stiffness or BP is a major CVD 
295 risk factor (49), which, when decreased significantly, reduces the risk of CVD and death in 
296 various populations (50). Various fruits, vegetables, and beverages that are commonly 
297 consumed in the human diet can be rich in anthocyanins (51-53) Therefore, the present findings 
298 emphasize the importance of incorporating more anthocyanin-rich foods, including fruits and 
299 vegetables and berries such as NZBC, which promote cardiovascular health without side effects.
300 This study has some limitations. First, the short time frame of the study might have 
301 prevented observation of the benefits of longer-term consumption on arterial stiffness and BP. 
302 Second, vascular endothelial function, antioxidant capabilities, and inflammatory markers were 
303 not measured. Third, the results in this study population of healthy older adults might not be 
304 generalizable to CVD patients. Finally, there was no information on anthocyanin-derived 
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305 metabolites with 7-day NZBC intake. Nevertheless, to the best of our knowledge, the present 
306 data provide the first evidence that short-term intake of NZBC may contribute to reductions in 
307 central arterial stiffness and BP in older adults. Further long-term, randomized, interventional 




312 In conclusion, the findings of the present study indicate that short-term NZBC intake 
313 reduces central arterial stiffness and BP in older adults. These results suggest that habitual 
314 NZBC intake may be an effective way to prevent CVD. Therefore, anthocyanin-rich 
315 blackcurrants might be beneficial for maintaining or improving cardiovascular health as an 
316 alternative to pharmaceutical medications.
317
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525 Figure legends
526 Figure 1. Consort flow diagram of the participants
527 Figure 2. Experimental schedule
528 Figure 3. Changes in cfPWV before and after both NZBC and placebo 
529 *: significantly (P<0.05) different from before. 
530 †: significantly (P<0.05) different from placebo.
531 cfPWV, carotid-femoral pulse wave velocity; NZBC, New Zealand blackcurrants
532 Figure 4. Changes in central BP before and after both NZBC and placebo 
533 *: significantly (P<0.05) different from before.
534 ††: significantly (P<0.01) different from placebo.
535 SBP, systolic blood pressure; NZBC, New Zealand blackcurrants
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Body mass index (kg/m2) 21.6±0.7
Body fat (%) 25.7±1.7
537 Values are mean ± SEM.
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538 Table 2. Brachial SBP, DBP, MBP, PP, AIx, and faPWV before and after NZBC and placebo
　 NZBC Placebo
　 Before After Before After
Brachial SBP (mmHg) 142±5 133±3*,†† 140±5 142±4
Brachial DBP (mmHg) 79±3 76±2*,‡ 79±3 79±3
Brachial MBP (mmHg) 100±3 95±3**,†† 98±3 100±3
Brachial PP (mmHg) 63±4 58±2#, † 60±3 63±3
AIx (%) 87±4 83±3*,† 89±3 86±3
faPWV (cm/sec) 1239±49 1186±50 1234±55 1214±44
539 Values are mean ± SEM. *: significantly (P<0.05) difference from before. **: significantly 
540 (P<0.01) difference from before. #: denotes a strong trend for a different from baseline (p = 
541 0.09). †: significantly (P<0.05) difference from the placebo. ††: significantly (P<0.01) 
542 difference from the placebo. ‡: Denotes a strong trend for a different between NZBC and 
543 placebo trials (p = 0.07).
544 SBP, systoloc blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; PP, 
545 pulse pressure; AIx, augmentation index; faPWV, femoral-ankle pulse wave velocity; NZBC, 
546 New Zealand blackcurrant 
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547 Table 3. Serum Lipids profile and glucose before and after NZBC and placebo
　 NZBC Placebo
　 Before After Before After
TG (mg/dL) 88±12 85±8 95±10 93±10
HDL-C (mg/dL) 73±5 76±4 71±6 74±5
LDL-C (mg/dL) 124±10 120±8 127±7 127±5
FG (mg/dL) 91±4 91±3 92±4 91±4
548 Values are mean ± SEM. NZBC, New Zealand blackcurrant; TG, triglycerides; HDL-C, high-
549 density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; FG, fasting 
550 glucose
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Figure 1. Consort flow diagram of the participants 
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Figure 2. Experimental schedule 
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Figure 3. Changes in cfPWV before and after both NZBC and placebo 
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Figure 4. Changes in central BP before and after both NZBC and placebo 
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